Acute Leukemia: First-In-Class Treatment

EUREKA project E! 3172 NKSTIM has produced a new potential drug to stimulate cancer patients’ own ‘natural killer’ cells to attack and eliminate cancer cells; currently undergoing clinical testing in patients with leukaemia or myeloma. Existing knowledge of how transplanted bone marrow cells eradicate tumours gave the foundation for designing the new drug…

source : www.medicalnewstoday.com

Related News:

• Cordyceps mushroom is an effective cancer treatment, states new research
• Fesoterodine For The Treatment Of Urinary Incontinence And Overactive Bladder
• Benign Prostatic Hyperplasia: Symptoms, Symptom Scores, And Outcome Measures
• Costs Of Adverse Events In First-Line Metastatic Renal Cell Carcinoma Treatment: Bevacizumab In Combination With Interferon-a2a Vs Sunitinib
• Diabetes Experts Call For Early, Integrated Treatment Approach To Help Prevent Complications And Improve Patient Outcomes
• Growth Of Chronic Kidney Disease Highlights Need For Early Detection, Greater Knowledge Of Treatment Options
• Reovirus may be a novel approach to prostate cancer treatment
• Auxilium Announces Availability Of XIAFLEXTM For The Treatment Of Dupuytren’s Contracture
• Enobia Pharma Taps McGill Expertise In Developing First Effective Treatment For Rare Genetic Disorder
• Novo Nordisk Receives FDA Approval For Norditropin® FlexPro® For Growth Hormone Treatment